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Cation permeability proﬁleWe previously reported that TRPV4 and TRPC1 can co-assemble to form heteromeric TRPV4–C1 channels [12].
In the present study, we characterized some basic electrophysiological properties of heteromeric TRPV4–C1
channels. 4α-Phorbol 12,13-didecanoate (4α-PDD, a TRPV4 agonist) activated a single channel current in
HEK293 cells co-expressing TRPV4 and TRPC1. The activity of the channels was abrogated by a TRPC1-
targeting blocking antibody T1E3. Conductance of the channels was ~95 pS for outward currents and ~83 pS
for inward currents. The channels with similar conductance were also recorded in cells expressing TRPV4–C1
concatamers, in which assembled channels were expected to be mostly 2V4:2C1. Fluorescence Resonance
Energy Transfer (FRET) experiments conﬁrmed the formation of a protein complex with 2V4:2C1
stoichiometry while suggesting an unlikeliness of 3V4:1C1 or 1V4:3C1 stoichiometry. Monovalent cation
permeability proﬁles were compared between heteromeric TRPV4–C1 and homomeric TRPV4 channels. For
heteromeric TRPV4–C1 channels, their permeation proﬁle was found to ﬁt to Eisenman sequence VI,
indicative of a strong ﬁeld strength cation binding site, whereas for homomeric TRPV4 channels, their
permeation proﬁle corresponded to Eisenman sequence IV for a weak ﬁeld strength binding site. Compared to
homomeric TRPV4 channels, heteromeric TRPV4–C1 channels were slightly more permeable to Ca2+ and had
a reduced sensitivity to extracellular Ca2+ inhibition. In summary, we found that, when TRPV4 and TRPC1
were co-expressed in HEK293 cells, the predominate assembly type was 2V4:2C1. The heteromeric TRPV4–C1
channels display distinct electrophysiological properties different from those of homomeric TRPV4 channels.ration; CFP, cyan ﬂuorescent
orescence Resonance Energy
transient receptor potential
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TRP channels are a superfamily of cation channels that can be
divided into seven subfamilies including TRPC, TRPV, and ﬁve others.
Functional TRP channels are tetrameric complexes consisting of four
pore-forming subunits [1], which can be identical (homotetrameric)
or different (heterotetrameric) [2–4]. Heteromeric assembly usually
occurs between the members within the same TRP subfamily such as
between TRPC1 and TRPC5, TRPV5 and TRPV6, TRPM6 and TRPM7
[1,3,5]. However, cross-subfamily heteromerization has also been
reported, which includes TRPC1–TRPP2 [6–9] and TRPV4–TRPP2
[10,11].
Recently, we have identiﬁed a new type of cross-subfamily
heteromeric TRP channels, i.e. TRPV4–C1 channels [12]. The main
evidences were as follows: 1) FRET, co-immunoprecipitation andsubcellular immunocolocalization methods showed that TRPV4 and
TRPC1 could associate with each other to form a physical complex
[12]. 2) 4α-PDD and ﬂuid ﬂow, two stimuli that are commonly used to
activate TRPV4, could induce Ca2+ inﬂux and stimulate cation
currents in HEK cells co-expressing TRPV4 and TRPC1. The Ca2+
inﬂux and cation currents could be inhibited either by T1E3 [12],
which is an antibody targeted at the pore region of TRPC1 and has
been shown to inhibit store-operated Ca2+ entry in vascular cells [13],
or by TRPC1Δ567–793 [12], which is a mutant with deletion in TRPC1
pore-forming region [14]. These data suggested that the pore regions
of TRPC1 and TRPV4 were closely appositioned to each other, likely to
form heterotetrameric channels that shared a common pore, similar
to those reported for heterotetrameric TRPC1-P2 channels [6].
In the present study, we characterized some basic electrophysio-
logical properties of TRPV4–C1 heteromeric channels, with special
emphasis on the channel pore properties including single channel
conductance, permeability ratio to different cations, I–V relationship,
and voltage-dependent block by extracellular Ca2+. Our data show
that heteromeric TRPV4–C1 channels have distinct properties that are
different from homomeric TRPV4 channels with regard to the relative
permeability to monovalent cations, voltage-dependent block by
extracellular Ca2+.
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2.1. Cell culture
HEK293 cells were cultured in DMEM supplemented with 10% FBS,
100 μg/ml penicillin and 100 U/ml streptomycin.
2.2. Cloning and transfection
Human TRPC1 cDNA (NM_003304) was obtained by RT-PCR from
human coronary endothelial cells CC2585 (BioWhittaker). TRPC1Mut-pore
was a gift from Dr. Indu Ambudkar, NIH, USA. In this construct,
substitutions (Asp→Asn and Glu→Gln) were made at the seven
negatively charged residues present in the region between S5 and S6
where TRPC1 pore is located [14]. For FRET, TRPV4 was tagged with CFP
or YFP at its C-terminus, and TRPC1 was tagged with CFP or YFP at its C-
terminus, TRPV4–C1 concatamer was tagged with CFP or YFP at its C-
terminus.
Transfection condition was as described elsewhere [15]. Brieﬂy,
HEK293 cells were transfected with various constructs using
Lipofectamine 2000. About 6×104 HEK293 cells were grown in each
well of 6-well plates. Transfection was done with 4 μg DNA per
plasmid with a total of 4–12 μg plasmid DNA, mixed with 6 μl
Lipofectamine 2000 in 200 μl Opti-MEM reduced serummedium in 6-
well plates. Unless stated otherwise, the ratio of co-transfected
constructs was 1:1. Functional studies were performed 2–3 days post-
transfection.
2.3. Preparation of T1E3 and preimmune IgG
T1E3 antibody was raised in rabbits using the strategy developed
by Xu et al. [13]. Brieﬂy, a peptide corresponding to TRPC1 putative
pore-region (CVGIFCEQQSNDTFHSFIGT) was synthesized and conju-
gated to keyhole limpet hemocyanin (KLH) at Alpha Diagnostic
International (USA). The coupled T1E3 peptide (0.5 mg) was injected
to the back of a rabbit (day 0), followed by two boost doses at day 21
and day 42 respectively. Antiserumwas collected four weeks after the
second boost. Immunoglobin G was puriﬁed from the T1E3 antiserum
using a HiTrap Protein G column (GE Healthcare). For control, pre-
immune serumwas puriﬁed with a HiTrap Protein G column to obtain
the immunoglobin G, and then was used in experiments. The applied
T1E3 and preimmune IgG were of similar protein quantities in order
to balance possible osmotic effect.
2.4. Fluorescence Resonance Energy Transfer (FRET) detection
CFP (or YFP)-tagged TRPV4, -tagged TRPC1, and -tagged TRPV4–C1
concatamers were transfected into HEK cells with different combina-
tions. In general, the ratio of co-transfected constructs was 1:1. In
experiments where untagged TRPV4 or TRPC1 was used, the ratio of
untagged TRPV4 (or TRPC1) vs. CFP-tagged concatamer vs. YFP-
tagged concatamer was 4:1:1. FRET signals were detected as
described elsewhere [16]. Brieﬂy, an inverted microscope equipped
with three-cube FRET ﬁlters and CCD camera was used to measure
FRET. Three-cube FRET ﬁlter cubes were listed as follows (excitation;
dichroic; emission): YFP (S500/20 nm; Q515lp; S535/30 nm); FRET
(S430/25 nm; 455dclp; S535/30 nm); and CFP (S430/25 nm; 455dclp;
S470/30 nm). Average background signal was subtracted. FRET ratio
(FR) was calculated by the following equation:
FR =
FAD
FA
=
SFRET DAð Þ−RD1SCFP DAð Þ
 
RA1
 SYFP DAð Þ−RD2SCFP DAð Þ
 
in which FAD represents the total YFP emission with 430/25-nm
excitation, and FA represents the direct YFP emission with 500/20-nm
excitation. In SCUBE(SPECIMEN), CUBE indicates the ﬁlter cube (CFP,YFP, or FRET), and SPECIMEN indicates whether the cell is expressing
donor (D, CFP), acceptor (A, YFP), or both (DA). RD1=(SFRET(D))/(SCFP
(D)), RD2=(SYFP(D))/(SCFP(D)), and RA1=(SFRET(A))/(SYFP(A)) are
predetermined constants that require measurement of the bleed-
through of the emission of only CFP- or YFP-taggedmolecules into the
FRET channel and the emission of only CFP-tagged molecules into the
YFP channel.
2.5. Whole-cell patch clamp
Whole-cell membrane currents were monitored with an EPC-9
(HEKA Elektronik, Lambrecht, Germany; 8-Pole Bessel ﬁlter, 2.9 kHz)
using ruptured patches [12]. Patch electrodes had a DC resistance
between 2 and 4 mΩwhen ﬁlledwith intracellular solution. Capacitance
and access resistanceweremonitored continuously. Between50 and 70%
of the series resistance was electronically compensated to minimize
voltage errors. Pipette and bath solutions were as described [17]. The
pipette solution contained inmM: 20 CsCl, 100 Cs+-aspartate, 1MgCl2, 4
ATP, 0.08 CaCl2, 10 BAPTA, 10 Hepes, pH 7.2. Free intracellular Ca2+ was
calculated to be ~1 nM for the solution with “webmaxc” available at
http://www.stanford.edu/∼cpatton/webmaxcS.html [18]. The bath solu-
tion contained inmM: 150NaCl, 6 CsCl, 1MgCl2, 1.5 CaCl2, 10 glucose, 10
Hepes, pH 7.4. Cells were clamped at 0 mV. I–V relationships were
generated by a ramp protocol consisted of a 100-ms linear ramp from
−100 mV to+100 mV, repeated every 5 s before and after 4α-PDD. The
maximal responses to 4α-PDD were plotted. For the magnitude of 4α-
PDD-stimulatedcurrents at+80mVand/or−80 mV,whole-cell current
density (pA/pF)was recorded in response to successive voltage pulses of
+80 mV and −80 mV for 100 ms duration. These whole-cell current
valueswere then plotted vs. time to generate a time course. Themaximal
responses to 4α-PDDwere then plotted in bar charts. The currents were
sampled at 25 kHz and ﬁltered at 1 kHz. All of the experiments were
performed at room temperature (20–23 °C). When needed, cells were
pretreated with T1E3 antibody or preimmune IgG for 1 h.
Reversal potential measurement for cation permeability estima-
tion was as described elsewhere [17,19]. The standard extracellular
solution contained in mM 150 NaCl, 1 MgCl2, 5 CaCl2, 10 glucose, 10
HEPES, pH 7.4 titrated with NaOH. When indicated in the ﬁgure
legends, the Ca2+ concentration of this solution was varied between
0 and 30 mM. To study the relative permeability of mono- and
divalent cations, we used extracellular solutions containing in mM: 1
MgCl2, 10 glucose, 10 HEPES, and either 150 XCl (where X = sodium,
cesium, or potassium) or 30 CaCl2 and 120 N-methyl-D-glucamine
chloride. These solutions were titrated to pH 7.4 with the appropriate
base. The pipette solution contained in mM: 150 NaCl, 1 MgCl2, 4
Na2ATP, 0.037 CaCl2, 5 EGTA, 10 HEPES, pH 7.2 titrated with NaOH,
free intracellular Ca2+ was calculated to be ~1 nM for the solution. A
ramp protocol consisted of a 100-ms linear ramp from −100 mV to
+100 mV, repeated every 5 s. 4α-PDD was applied to the extracel-
lular solution at a concentration of 5 μM. The relative permeability of
monovalent cations was calculated from the shift in reversal potential
after complete substitution of extracellular Na+ by the speciﬁc cation
[17,19], according to the following equation:
PX = PNa = exp ΔVrevF= RTð Þ ð1Þ
where PX represents the permeability of the monovalent cation. ΔVrev
is the measured shift in reversal potential. Permeability of the Ca2+
relative to Na+ was calculated from the absolute reversal potential
measured with 30 mM of the Ca2+ in the extracellular solution,
according to the following equation [17,19]:
PCa = PNa = ð1 + expð
ΔVrevF
RT
ÞÞ ð Na½ i + α Cs½ iÞ exp VrevF = RTð Þ− Na½ e−α Cs½ e
4 Ca½ e
ð2Þ
where α is PCs/PNa obtained from Eq. 1, [Na+]e, [Na+]i, [Cs+]e, [Cs+]i
are the extra- and intracellular concentration of Na+ and Cs+,
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reversal potentials were corrected for liquid junction potentials.
Note that the current–voltage curves in Figs. 5 and 6 are raw traces
without correction for liquid junction potential.
2.6. Cell-attached single channel patch clamp
Cell-attached single channel currents were monitored with an
EPC-9 (HEKA Elektronik, Lambrecht, Germany), as described else-
where [20]. Single-channel currents were sampled at 200- and 500-s
intervals and ﬁltered at 2 and 1 kHz for HEK293 cells. The pipette
solution contained in mM: 150 NaCl, 1 MgCl2, 10 Na–HEPES pH 7.4
and the bath solution was 150 KCl, 5 MgCl2, 10 HEPES, 10 glucose (pH
adjusted to 7.4 with KOH). The recordings weremade before and after
4α-PDD (5 μM) application. If needed, T1E3 (1:200) or pre-immune
IgG (1:200) was introduced into the pipette solution [21–23].
2.7. Statistics
Student's t test or one-way analysis of variance followed by
Newman–Keul's test were used for statistical comparison when
appropriate, with probability pb0.05 as a signiﬁcant difference.
3. Results
3.1. Single channel properties of heteromeric TRPV4–C1 channels
Previous studies using whole-cell patch clamp have demonstrated
the existence of heteromeric TRPV4–C1 channels in HEK293 cells co-
expressing TRPV4 and TRPC1 [12]. In the present study, we examined
the properties of heteromeric TRPV4–C1 channels at single channel
level. In cell-attached mode, 4α-PDD (5 μM, a TRPV4 agonist)-
activated channels could be detected in cells expressing TRPV4 and
those co-expressing TRPV4 and TRPC1 (Fig. 1). In the absence of 4α-
PDD, both channels had very little activity. For the channels in TRPV4-
expressing cells, application of 4α-PDD (5 μM) increased their open
probability (Po) from 0.03±0.01 (n=6) to 0.71±0.05 (n=7, Fig. 2A
and C). Single channel slope conductance was estimated to be 63±
3 pS (n=7) for inward currents and 85±2 pS (n=7) for outward4 PDD
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Fig. 1. Single channel activity of cell-attached patches from HEK cells expressing different co
and TRPC1; C and F, HEK cells expressing TRPV4–C1 concatamers. A, B and C, representative
patch membrane was held at +60 mV. Channel close level was marked as c. D, E and F, Sin
attached patches. Mean±SEM (n=6–20 patches).currents (Fig. 1D). 4α-PDD (5 μM) also activated the channels in
TRPV4–C1 co-expressing cells with Po increased from 0.02±0.01
(n=6) to 0.73±0.03 (n=8, Fig. 2B and D). In cells co-expressing
TRPV4 and TRPC1, the majority of patches (15 out of 18 patches)
contained a channel with single channel slope conductance of 83±
2 pS (n=15) for inward currents and 95±3 pS (n=15) for outward
currents (Fig. 1E). In the minority of patches (3 out of 18), another
channel with slightly smaller conductance was recorded, which had
conductance of 78±1 pS (n=3) for inward currents and 86±2 pS
(n=3) for outward currents. A TRPC1-speciﬁc blocking antibody
T1E3was used [13]. In this set of experiments, the patch pipettes were
backﬁlled with T1E3 using a two-step protocol [24,25]. T1E3 would
slowly diffuse from the pipette onto the membrane, causing a time-
dependent inhibition on TRPC1-related channels on cell-attached
membrane patches. As expected, T1E3 (1:200) had no effect on the
channels in TRPV4-expressing cells, which were presumably homo-
meric TRPV4 channels (Fig. 2A and C). In contrast, T1E3 (1:200)
inhibited the channels in cells co-expressing TRPV4 and TRPC1,
suggesting that the channels were heteromeric TRPV4–C1 channels
(Fig. 2B and D).
TRPV4–C1 concatamers were constructed. In cells expressing
TRPV4–C1 concatamers, the recorded channels had single channel
conductance of 84±3 pS (n=17) for inward currents and 93±3 pS
(n=17) for outward currents (Fig. 1C and F). These values were very
similar to the major type of channels recorded from the cells co-
expressing individual TRPV4 and TRPC1 (Fig. 1B and E).
3.2. Whole-cell properties of heteromeric TRPV4–C1 channels
4α-PDD-stimulated whole-cell currents were examined in cells
expressing TRPV4, co-expressing TRPV4 and TRPC1, and expressing
TRPV4–C1 concatamers. In all cell types, 4α-PDD-stimulated currents
displayed relatively linear current–voltage relationships with a slightly
outward rectiﬁcation at positive voltage when the bath solution
contained physiological concentration of mono- and divalent cations
(Fig. 3A, B and D). Previously, we have demonstrated that T1E3 could
inhibit ﬂow-induced [Ca2+]i rises in cells co-expressing TRPV4 and
TRPC1 [12]. Here the whole-cell patch clamp showed that T1E3 (1:200)
incubation for 1 h decreased the 4α-PDD-stimulatedwhole-cell currents+C1
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Fig. 2. Effect of T1E3 on 4α-PDD-activated single channels in cell-attached patches from HEK cells expressing different constructs. A and C, HEK cells expressing TRPV4; B and D, HEK
cells co-expressing TRPV4 and TRPC1. A and B, representative single channel traces. Three traces from left to right represent those “after seal formation”, “immediately after 5 μM4α-
PDD”, followed by “2 min later after diffusion of T1E3 (1:200) or preimmune IgG (1:200, as control) to the patch membrane”. The patch membrane was held at +60 mV. The
amplitude histograms of the respective traces are shown under the representative traces. C and D, Single channel open probability (Po) values of 4α-PDD-activated channels in cells
expressing TRPV4 (C) and those co-expressing TRPV4 and TRPC1 (D). Po values were calculated from multiple patches for a 20-s period. Mean±SEM (n=6–8 patches). #, Pb0.05
compared to preimmune IgG with 4α-PDD.
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TRPC1Mut-pore, which carries the point mutations at TRPC1 pore region
[14], also drastically reduced the 4α-PDD-stimulated currents by 81±1%
(n=8) in these cells (Fig. 3BandC).Direct applicationof T1E3 to thebath
solution also markedly reduced the 4α-PDD-stimulated whole-cell
currents within 2–3 min (Fig. 3E and F).
3.3. FRET studies on the stoichiometry of heteromeric
TRPV4–C1 channels
FRET was then used to further examine the subunit assembly of
TRPV4 and TRPC1. Previously, we have used FRET to demonstrate the
physical interaction of TRPV4 and TRPC1 in HEK293 cells co-
expressing individual TRPV4 and TRPC1 [12]. Here we found positiveFRET signals in cells co-expressing CFP-tagged TRPV4–C1 concata-
mers and YFP-tagged TRPV4–C1 concatamers (Fig. 4), supporting the
formation of channels with 2V4:2C1 stoichiometry. However, no FRET
signal was observed in cells co-expressing CFP-tagged TRPV4–C1
concatamers and YFP-tagged TRPV4, or in cells co-expressing CFP-
tagged TRPV4–C1 concatamers and YFP-tagged TRPC1 (Fig. 4),
suggesting that neither 3V4:1C1 nor 1V4:C1 stoichiometry was
favored. These negative data on FRET were not due to the “problem”
with YFP-tagged TRPV4 and YFP-tagged TRPC1 constructs, because
these two constructs could generate positive FRET signals when
paired with CFP-tagged TRPV4 and TRPC1, respectively (Fig. 4). For
positive control, signiﬁcant FRET signals were observed in cells
expressing CFP–YFP concatamers (Fig. 4). No FRET signal was detected
in a negative control, in which cells were co-transfected with CFP-
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inwardly rectifying potassium channels bearing no similarity to TRP
channels, and it served as a membrane protein control.
We also examined whether co-expression of untagged TRPV4 or
untagged TRPC1 could interfere the interaction between two V4–C1
concatamers (Fig. 4). The results show that untagged TRPC1 or TRPV4
did not alter the FRET signals generated from the interaction between
CFP-tagged TRPV4–C1 concatamers and YFP-tagged TRPV4–C1 con-
catamers, further supporting the preference and stability of 2V4:2C1
stoichiometry.
3.4. Mono- and divalent cation permeability of TRPV4–C1
heteromeric channel
Relative permeability of homomeric TRPV4 and heteromeric
TRPV4–C1 channels to Na+, Rb+, K+, Li+ and Ca2+ was estimated
based on reverse potential measurement of 4α-PDD-stimulated
cation currents using the methods established previously [17]. After
full activation of the currents with 4α-PDD (5 μM), extracellular
solutions were switched to the ones that contain different permeant
cation species, for example from K+-containing to Cs+-containingbath solution. The relative permeability was then calculated from the
shifts in the reversal potential. The results showed that TRPV4 was
moderately selective for Ca2+ over Na+ ions with PCa:PNa=7.1:1 (Fig.
5D), and its relative permeability sequences for monovalent cations
were PK:PRb:PCs:PNa:PLi=1.42:1.31:1.28:1:0.79 (Fig. 5A), correspond-
ing to Eisenman sequence IV. In contrast, the channels recorded from
cells co-expressing individual TRPV4 and TRPC1 and those expressing
TRPV4–C1 concatamers were more permeable to Ca2+ with PCa:
PNa=9.2:1 and 9.3:1, respectively (Fig. 5E and F). The monovalent
cation permeability of the latter two was very close, with PK:PNa:PRb:
PCs:PLi=1.44:1:0.93:0.77:0.68 for cells co-expressing individual
TRPV4 and TRPC1 and 1.46:1:0.95:0.79:0.68 for cells expressing
TRPV4–C1 concatamers (Fig. 5B and C), both corresponding to
Eisenman sequence VI.
Met-680 of TRPV4 is a crucial residue positioned at the pore region
of TRPV4 (17). Conversion of Met-680 to aspartic acid caused a drastic
reduction in current density for cells expressing TRPV4 or co-
expressing TRPV4 and TRPC1 (Fig. 5J). After replacing TRPV4 with
TRPV4M680D, switching extracellular solution from a Na+-containing
solution to a Ca2+ (30 mM)-containing solution as the sole permeant
cation caused a leftward shift of the reversal potential corresponding
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Met-680 to aspartic acid abolished the Ca2+ permeability of both
homomeric TRPV4 and heteromeric TRPV4–C1 channels.
3.5. Voltage-dependent inhibition of TRPV4–C1 heteromeric channels by
extracellular Ca2+
It was reported that extracellular Ca2+ caused a voltage-
dependent inhibition on homomeric TRPV4 channels [17]. This was
conﬁrmed in the present study. In the absence of divalent cations, the
current–voltage relation of homomeric TRPV4 was linear (Fig. 6A).
Extracellular Ca2+ caused a concentration-dependent inhibition of
the currents that was more pronounced at negative potentials,
characteristic of a voltage-dependent block (Fig. 6A). However, for
cells co-expressing TRPV4 and TRPC1 and for those expressing
TRPV4–C1 concatamers, the voltage-dependent blockage by extracel-
lular Ca2+ was much smaller than that of homomeric TRPV4 channels
(Fig. 6B and C). This was especially evident at negative membrane
potential. At −80 mV, 30 mM extracellular Ca2+ only reduced the
whole-cell currents by 46±7% (n=6) for cells expressing TRPV4–C1
concatamers (Fig. 6C and D) and 46±4% (n=4) for those co-expressing individual TRPV4 and TRPC1 (Fig. 6B and D), respectively.
In contrast, the same concentration of extracellular Ca2+ reduced the
current density of homomeric TRPV4 channels by a much large degree
of 74±8% (n=5) (Fig. 6A and D).
4. Discussion
Recently, we have found a novel type of cross-subfamily hetero-
meric channels, TRPV4–C1 channels [12]. In the present study, we
characterized some basic electrophysiological properties of this
heteromeric TRPV4–C1 channels. The major type of channels in cells
co-expressing TRPV4 and TRPC1 had single channel conductance of
83 pS for inward currents and 95 pS for outward currents. It is likely
that this channel type represents 2V4:2C1 stoichiometry. When
compared to homomeric TRPV4 channels, these heteromeric TRPV4–
C1 channels were slightly more permeable to Ca2+, displayed
different monovalent permeation proﬁle, and had a reduced sensi-
tivity to extracellular Ca2+ inhibition.
4α-PDD-activated channels recorded from the cells co-expressing
TRPV4 and TRPC1 were not very different from homomeric TRPV4 in
terms of their single channel conductance (~95 pS vs. ~85 pS for
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homomeric TRPC1was reported to be at ~16 pS [26]. Onemaywonder
whether the recorded channels from the cells co-expressing TRPV4
and TRPC1 indeed represented heteromeric TRPV4–C1 channels or
they were just homomeric TRPV4. A TRPC1-speciﬁc blocking antibody
T1E3 was used to differentiate these two possibilities. T1E3 targeted
against the ion permeation pore of TRPC1 channels [13], therefore
T1E3 was expected to inhibit heteromeric TRPV4–C1 channels but not
homomeric TRPV4. Our results showed that the channels were
inhibited by T1E3, suggesting that they were indeed heteromeric
TRPV4–C1 channels. In whole-cell patch recordings, T1E3 and a TRPC1
pore-dead mutant TRPC1Mut-pore each reduced 4α-PDD-stimulated
whole-cell currents by ≥80%, even though TRPC1 and TRPV4 were
transfected to the cells at a molecular ratio of 1:1. These results
suggested the relative abundance of heteromeric TRPV4–C1 vs.
homomeric TRPV4 of at least 4:1 in these cells. This ratio of 4:1
could be underestimated because these treatments were not expected
to fully abolish TRPV4–C1-mediated currents. Note that only 4α-PDD-
activated channels were studied here. Homomeric TRPC1 could not be
activated by 4α-PDD, thus were not studied here.
Heteromeric TRPV4–C1 channels could have different subunit
stoichiometry including 3V4:1C1, 2V4:2C1, and 1V4:3C1. It would be
interesting to know which assembly type may dominate. To addressthis question, TRPV4–C1 concatamers were constructed. It was
expected that the expression of TRPV4–C1 concatamers would mostly
result in the formation of channels with 2V4:2C1 stoichiometry,
assuming that the contribution of endogenous TRPV4 and TRPC1 was
small. Previous studies reported that the expression of TRPV4 and
TRPC1 in non-transfected HEK293 cells was indeed very low [12]. In
the present study, 4α-PDD-activated single channelswere recorded in
cells expressing TRPV4–C1 concatamers, and the channels were found
to be very close to the major type of channels in cells co-expressing
individual TRPV4 and TRPC1 with regards to single channel
conductance. Importantly, FRET studies conﬁrmed the formation of
protein complex with 2V4:2C1 stoichiometry while suggesting the
unlikeliness of 3V4:1C1 or 1V4:3C1 stoichiometry. Therefore, it was
likely that the main assembly type in cells co-expressing individual
TRPV4 and TRPC1 was 2V4:2C1. However, it should be noted that
there was a minority type of channels with relatively smaller
conductance (78 pS for inward currents and 86 pS for outward
currents) presented in cells co-expressing individual TRPV4 and
TRPC1. Those could represent the channels with other subunit
stoichiometries such as 3V4:1C1 or 1V4:3C1. One point to consider
is that 1V4:3C1 stoichiometry has only one V4 subunit, which may or
may not be sufﬁcient for 4α-PDD response. Regardless of their exact
stoichiometry, low abundance of these channels made it difﬁcult to
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whether this minority type of channels were also sensitive to T1E3
inhibition. Low abundance could also explain why we failed to detect
positive FRET signals for these types of stoichiometries. It is possible
that these types of heteromerization may be below the detection
limits of our FRET experiments. Our conclusion of 2V4:2C1 stoichi-
ometry appears to agree with several recent reports, which
demonstrated the same 2:2 subunit stoichiometry for two other
cross-subfamily TRP channels, i.e., heteromeric TRPV4-P2 and
heteromeric TRPC1-P2 channels [9,11].
Previous studies showed that homomeric TRPV4 has a weak Ca2+
selectivity over Na+ with the relative permeability ratio of PCa:
PNa=6.9:1, and its monovalent permeation proﬁle corresponds to
Eisenman sequence IV, indicating a weak ﬁeld strength cation binding
site [17,27]. This was conﬁrmed by the present study, in which we
showed relative cation permeability ratio of PCa:PK:PCs:PNa=7.1:
1.4:1.2:1 for homomeric TRPV4, similar to the reported value (17).
In comparison, the channels recorded from cells co-expressing
TRPV4–C1 channels and those expressing TRPV4–C1 concatamers
were slightly more selective for Ca2+ with PCa:PNa=9.2:1, and
displayed different monovalent permeation proﬁle of Eisenman
sequence VI, indicative of a strong ﬁeld strength cation binding site.
Previous evidence suggested that Met-680 of TRPV4 was crucial for
the proper functioning of the TRPV4 pore [17]. Introducing a negative
charge at this position (M680D) was found to cause a reduction in
current density and a complete loss of Ca2+ permeation [17]. In the
present study, we found that conversion of Met-680 to aspartic acid
(D) also reduced the Ca2+ permeability of heteromeric TRPV4–C1
channels. These data suggested that Met680 was not only crucial for
the proper functioning of homomeric TRPV4 pore, but also important
for the proper functioning of heteromeric TRPV4–C1 pore. Anothermarked difference between homomeric TRPV4 and heteromeric
TRPV4–C1 was their sensitivity to extracellular Ca2+ inhibition. We
found that extracellular Ca2+ inhibited heteromeric TRPV4–C1 at a
much less degree comparing to its inhibition on homomeric TRPV4.
In conclusion, the present study demonstrated that, in HEK cells
co-expressing TRPV4 and TRPC1, the predominate assembly type was
the heteromeric channels with stoichiometry of 2TRPV4:2TRPC1.
Different from homomeric TRPV4, these heteromeric TRPV4–C1
channels have reduced sensitivity to extracellular Ca2+ inhibition
and display different monovalent permeation proﬁle.
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